PNC Financial Services Group
TBIO

PNC Financial Services Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

PNC Financial Services Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-540
Closed -$14K – 4496
2021
Q2 		$14K Sell
540
-80
-13% -$1.57K ﹤0.01% 3613
2021
Q1 		$10K Buy
620
+140
+29% +$3.19K ﹤0.01% 3662
2020
Q4 		$8K Buy
480
+280
+140% +$5.01K ﹤0.01% 3633
2020
Q3 		$3K Hold
200
– – ﹤0.01% 3790
2020
Q2 		$4K Buy
+200
New +$3.02K ﹤0.01% 3702

PNC Financial Services Group's TBIO Position: Q3 2021 in Review

PNC Financial Services Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 540 shares — an estimated $14K sold.

PNC Financial Services Group first reported a position in TBIO in Q2 2020 and held it in 5 quarters. The position peaked at $14K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • PNC Financial Services Group reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 540 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $14K.
  • PNC Financial Services Group first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • PNC Financial Services Group's Translate Bio, Inc. Common Stock position peaked at $14K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on PNC Financial Services Group's 13F filing for Q3 2021, filed 5 Nov 2021.